<DOC>
	<DOCNO>NCT02477514</DOCNO>
	<brief_summary>The purpose study assess effect steady-state tedizolid phosphate single-dose pharmacokinetics midazolam rosuvastatin healthy , adult participant .</brief_summary>
	<brief_title>A Study Evaluate Effects Tedizolid Phosphate Pharmacokinetics Safety Midazolam Rosuvastatin ( MK-1986-004 )</brief_title>
	<detailed_description />
	<mesh_term>Skin Diseases</mesh_term>
	<mesh_term>Skin Diseases , Bacterial</mesh_term>
	<mesh_term>Torezolid phosphate</mesh_term>
	<mesh_term>Torezolid</mesh_term>
	<mesh_term>Oxazolidinones</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<criteria>healthy , adult male female ( woman nonchildbearing potential ) continuous nonsmoker use nicotinecontaining product previous 3 month mentally legally incapacitated significant emotional problem history presence clinically significant medical psychiatric condition disease history presence alcoholism drug abuse within past 2 year female participant pregnant , lactating , childbearing potential donate blood significant blood loss within 56 day prior first dose study drug plasma donation within 7 day prior first dose study drug</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>